Three generations of family were on hand at the 91¶¶Òõ Dome to help him celebrate – his mother Precious, his wife Jana and their four-year-old daughter Masiwa.
Left to right: Brian Jones, Dr Lubinda Mbundi and Professor Matteo Santin.
Also, present to congratulate him was , Professor of Tissue Regeneration in the School of Pharmacy and Biomolecular Sciences, and Brian Jones, Chief Executive of Orthopaedic Research UK, the charity which funds high-quality research into orthopaedic science, and which sponsored Lubinda’s research.
Lubinda’s PhD was awarded in recognition of a programme of work entitled “Nanostructured biocompetent biomaterials for early diagnosis and treatment of osteoporotic fractures.”
His research focussed on the diagnosis and treatment of bone tumours and fractures in the least invasive way possible. The materials developed in his work specifically target diseased tissue, act as the drug and are traceable. The Orthopaedic Research UK charity has supported a patent application to cover the technology and they are interested in its future translation into clinics.
Lubinda, who first studied for a degree in Biomedical Science at 91¶¶Òõ, recently took up a Post-Doctoral position at the Blond McIndoe Foundation Research Centre based at Queen Victoria Hospital in East Grinstead, which has strong research links with university.
Lubinda’s PhD was awarded in recognition of a programme of work entitled “Nanostructured biocompetent biomaterials for early diagnosis and treatment of osteoporotic fractures.” Also, present to congratulate him was Professor Matteo Santin, Professor of Tissue Regeneration in the School of Pharmacy and Biomolecular Sciences, and Brian Jones, Chief Executive of Orthopaedic Research UK, the charity which funds high-quality research into orthopaedic science, and which sponsored Lubinda’s research.
His research focussed on the diagnosis and treatment of bone tumours and fractures in the least invasive way possible. The materials developed in his work specifically target diseased tissue, act as the drug and are traceable. The Orthopaedic Research UK charity has supported a patent application to cover the technology and they are interested in its future translation into clinics.
Lubinda, who first studied for a degree in Biomedical Science at 91¶¶Òõ, recently took up a Post-Doctoral position at the Blond McIndoe Foundation Research Centre based at Queen Victoria Hospital in East Grinstead, which has strong research links with university.